Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2019 Oct;83(4S Suppl 1):S59-S64.
doi: 10.1097/SAP.0000000000002098.

Radiation-Induced Skin Fibrosis: Pathogenesis, Current Treatment Options, and Emerging Therapeutics

Affiliations
Review

Radiation-Induced Skin Fibrosis: Pathogenesis, Current Treatment Options, and Emerging Therapeutics

Mimi R Borrelli et al. Ann Plast Surg. 2019 Oct.

Abstract

Radiotherapy (RT) has become an indispensable part of oncologic treatment protocols for a range of malignancies. However, a serious adverse effect of RT is radiodermatitis; almost 95% of patients develop moderate to severe skin reactions following radiation treatment. In the acute setting, these can be erythema, desquamation, ulceration, and pain. Chronically, soft tissue atrophy, alopecia, and stiffness can be noted. Radiodermatitis can delay oncologic treatment protocols and significantly impair quality of life. There is currently a paucity of effective treatment options and prevention strategies for radiodermatitis. Importantly, recent preclinical and clinical studies have suggested that fat grafting may be of therapeutic benefit, reversing detrimental changes to soft tissue following RT. This review outlines the damaging effects of RT on the skin and soft tissue as well as discusses available treatment options for radiodermatitis. Emerging strategies to mitigate detrimental, chronic radiation-induced changes are also presented.

PubMed Disclaimer

Figures

Fig. 1.
Fig. 1.. The proposed mechanism underlying radiation-induced fibrosis (RIF).
A) RT delivers ions that directly induces DNA damage and generates reactive oxygen species (ROS). Damaged cells in the skin and endothelium (colored purple) release cytokines, leading to activation of the innate and adaptive immune systems and recruitment of inflammatory cells. B) Once recruited to the irradiated area, neutrophils release additional inflammatory mediators to sustain inflammation. Lymphocytes and monocytes also migrate to the location of injury, the latter of which differentiate into macrophages. Macrophages, fibroblasts, native endothelial cells, and epidermal cells release transforming growth factor-beta (TGF-β) which stimulates fibroblasts to differentiate into myofibroblasts. C) Myofibroblasts secrete excess amounts of extracellular matrix proteins, leading to increased tissue stiffness and thickness. Over time, RIF ensues and may persist even decades after radiation therapy.

References

    1. Mendelsohn FA, Divino CM, Reis ED & Kerstein MD Wound care after radiation therapy. Advances in skin & wound care 15, 216–224 (2002). - PubMed
    1. Delaney G, Jacob S, Featherstone C & Barton M The role of radiotherapy in cancer treatment: estimating optimal utilization from a review of evidence‐based clinical guidelines. Cancer: Interdisciplinary International Journal of the American Cancer Society 104, 1129–1137 (2005). - PubMed
    1. Porock D & Kristjanson L Skin reactions during radiotherapy for breast cancer: the use and impact of topical agents and dressings. European journal of cancer care 8, 143–153 (1999). - PubMed
    1. Porock D, Nikoletti S & Kristjanson L Management of radiation skin reactions: literature review and clinical application. Plastic Surgical Nursing 19, 185 (1999). - PubMed
    1. Martin M, Lefaix J-L & Delanian S TGF-β1 and radiation fibrosis: a master switch and a specific therapeutic target? International Journal of Radiation Oncology* Biology* Physics 47, 277–290 (2000). - PubMed

Publication types